Legis Daily

VALID Act of 2020

USA116th CongressHR-6102| House 
| Updated: 3/5/2020
Diana DeGette

Diana DeGette

Democratic Representative

Colorado

Cosponsors (1)
Larry Bucshon (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020 This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2020

Latest Companion Bill Action

S 116-3404
Introduced in Senate
Mar 5, 2020
Introduced in House
Mar 5, 2020
Referred to the House Committee on Energy and Commerce.
  • March 5, 2020

    Latest Companion Bill Action

    S 116-3404
    Introduced in Senate


  • March 5, 2020
    Introduced in House


  • March 5, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • S 116-3404: VALID Act of 2020
Administrative law and regulatory proceduresAdministrative remediesAdvisory bodiesCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careFederal preemptionFood and Drug Administration (FDA)Government information and archivesHealth technology, devices, suppliesLicensing and registrationsMedical tests and diagnostic methodsPerformance measurementUser charges and fees

VALID Act of 2020

USA116th CongressHR-6102| House 
| Updated: 3/5/2020
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020 This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2020

Latest Companion Bill Action

S 116-3404
Introduced in Senate
Mar 5, 2020
Introduced in House
Mar 5, 2020
Referred to the House Committee on Energy and Commerce.
  • March 5, 2020

    Latest Companion Bill Action

    S 116-3404
    Introduced in Senate


  • March 5, 2020
    Introduced in House


  • March 5, 2020
    Referred to the House Committee on Energy and Commerce.
Diana DeGette

Diana DeGette

Democratic Representative

Colorado

Cosponsors (1)
Larry Bucshon (Republican)

Energy and Commerce Committee

Health

Related Bills

  • S 116-3404: VALID Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdministrative remediesAdvisory bodiesCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careFederal preemptionFood and Drug Administration (FDA)Government information and archivesHealth technology, devices, suppliesLicensing and registrationsMedical tests and diagnostic methodsPerformance measurementUser charges and fees